« Previous
Next »
Seminars in Oncology
Volume 37, Issue 3
, Pages 243-257
, June 2010
Cellular Proliferation, Apoptosis and Angiogenesis: Molecular Targets for Nutritional Preemption of Cancer
References
- World Cancer Research Fund/American Institute for Cancer Research. Food nutrition, physical activity and the prevention of cancer: a global perspective; Washington, DC.
- . Molecular targets for bioactive food components. J Nutr. 2004;134:2492s–2498s
- . Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78:517S–520S
- . Nutritional interactions: credentialing of molecular targets for cancer prevention. Exp Biol Med. 2007;232:176–183
- . Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78:517s–520s
- . Targeting carcinogen metabolism by dietary cancer preventive compounds. Current Cancer Drug Targets. 2007;5:416–424
- . Nutrition and DNA repair-potential molecular mechanisms of action. Current Cancer Drug Targets. 2007;5:425–431
- . Nutrient regulation of tumor and vascular endothelial cell proliferation. Current Cancer Drug Targets. 2007;5:432–437
- . Using nutrigenomics to evaluate apoptosis as a preemptive target in cancer prevention. Current Cancer Drug Targets. 2007;5:438–446
- . Cancer preventive phytochemicals as speed breakers in inflammatory signaling involved in aberrant COX-2 expression. Current Cancer Drug Targets. 2007;5:447–458
- . Cancer prevention by dietary bioactive components that target the immune response. Current Cancer Drug Targets. 2007;5:459–464
- . Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents. Current Cancer Drug Targets. 2007;5:475–483
- . Molecular targets for nutritional preemption of cancer. Current Cancer Drug Targets. 2007;5:410–415
- . Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol Sin. 2007;28:1305–1315
- . The hallmarks of cancer. Cell. 2000;100:57–70
- . Cell cycle control as a basis for cancer chemoprevention through dietary agents. Frontiers Biosci. 2008;13:2191–2202
- Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000;288:1425–1429
- . Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol. 2005;32:452–457
- . Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007;245:232–241
- Genistein induces G2/M cell cycle arrest via stable activation of ERK ½ pathway in MDA-MB-231 breast cancer cells. Cell Bio Toxicol. 2008;24:401–409
- . Induction of G2/M arrest and inhibition of cyclooxyagenase-2 activity by curcumin in human bladder cancer T24 cell. Oncol Rep. 2006;15:1225–1231
- . Apigenin suppresses insulin-like growth factor 1 receprot signaling in human prostate cancer: an in vitro and in vivo study. Mol Carcinog. 2009;48:243–252
- Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells. J Biochem Mol Toxicol. 2009;23:71–79
- Effects pf resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int J Cancer. 2009;124:2780–2788
- . Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem. 2009;106:73–82
- . Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Cancer. 2004;24:187–192
- . Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer. 2008;123:41–50
- Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder T24 cells. Anticancer Res. 2005;25:971–979
- . Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res. 2003;63:52–59
- Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 2007;98:1447–1553
- . New insights on the anticancer properties of dietary polyphenols. Med Res Rev. 2006;26:747–766
- . Alterations of pRB1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett. 2004;203:1–12
- . Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci. 2007;12:5039–5051
- . Differential biological responses of green tea polyphenol in normal cells vs. cancer cells. Curr Appl Phys. 2005;5:449–452
- The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing. Proc Natl Acad Sci U S A. 2008;105:19750–19755
- . Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer derived cell lines. J Androl. 2007;28:282–293
- . Discovery of natural product chemopreventive agents using HL-60 cell differentiation as a model. Anticancer Res. 1995;15:233–239
- Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin. 2007;28:1274–1304
- . Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol. 2004;24:187–192
- . Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr. 2004;134:2229–2236
- Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer. 2004;48:198–206
- Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem. 2004;279:25813–25822
- . Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther. 2005;4:1250–1259
- . Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res. 2009;69:3695–3703
- . Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and γ-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int J Oncol. 2008;33:851–859
- Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol. 2008;1:19–27
- . Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, P13K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle. 2007;6:1102–1114
- . Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther. 2006;4:843–852
- . Health effects and bioavailability of dietary flavanols. Free Radic Res. 1999;S1:75–80
- . Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21/WAF1/CIP1. Cell Cycle. 2007;6:2953–2961
- . Inhibition by curcumin of dietylnitrosamine-induced hepatic hyperplasi, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol. 2000;38:991–995
- . Quantittation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 1998;19:419–424
- Inhibition of 7,12-dimethylbenz{a}antrhracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23:1307–1313
- . Comparison of low-fat dairy foods on epithelial cell proliferation and differentiation. Nutr Cancer. 2001;41:150–155
- Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients. Cancer. 2001;91:833–840
- Dietary fiber decreases colonic epithelial cell proliferation and protein synthetic rates in human subjects. Am J Physiol Endocrinol Metab. 2006;290:E1104–E1108
- Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2009;18:2933–2941
- A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90:578–586
- Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14:2377–2383
- . Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst. 2004;96:662–672
- . Apoptosis: measurement and technical issues. J Mol Cell Cardiol. 2005;38:15–20
- A novel dietary triterpene leueol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res. 2005;65:11203–11213
- . Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther. 2007;6:1013–1021
- Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppress8ing nuclear factor-6B via inhibition of the prosurivial Akt signaling pathway. J Pharmacol Experimental Ther. 2007;321:616–625
- . Down-regulation of c-FLIP contributes to the sensitization effect of 3,3′-diindolylmethane on TRAIL-induced apoptosis in cancer cells. Mol Cancer Ther. 2005;4:1972–1981
- . Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer. 2006;119:2575–2585
- . Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed Pharmacother. 2008;62:583–589
- Curcumin induces apoptosis through mitochondrial hyperpolization and mtDNA damage in human hepatoma G2 cells. Free Radic Med Biol. 2007;43:968–975
- . Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother. 2008;62:637–644
- Mechanisms of activation of caspase cascade during beta-carotene-induced apoptosis in human tumor cells. Nutr Cancer. 2003;47:76–87
- . Anticancer activity of genistein on implanted tumor of human SG7901 cells in nude mice. World J Gastronenterol. 2008;14:627–631
- . Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther. 2007;6:1938–1943
- . Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic Biol Med. 2008;44:1833–1845
- . Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res. 2008;87:401–406
- . Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer. 2007;110:1083–1094
- . Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol. 2009;63:351–362
- . Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Arch Med Res. 2008;39:162–168
- . Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G(2)/M arrest and apoptosis. Toxicol In Vitro. 2009;23:797–807
- . CD95's deadly mission in the immune system. Nature. 2000;407:789–795
- . Ablation of either p21 or Bax prevent p53-dependent apoptosis induced by green tea polypheon epigallocatechin-3-gallate. FASEB J. 2005;19:789–791
- . Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 1999;20:237–242
- . Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol Sci. 2005;26:318–326
- . Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004;11:63–69
- . Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev. 1998;7:351–354
- Phase 1 pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev. 2001;10:53–58
- . Food content, processing, absorption and metabolism of onion flavonoids. Crit Rev Food Sci Nutr. 2007;47:397–409
- . Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem Pharmacol. 2008;75:1946–1958
- Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer. 2002;98:761–769
- . Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005;218:141–151
- . Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res. 2003;63:6988–6995
- . Nutritional interactions: credentialing of molecular targets for cancer prevention. Exp Biol Med. 2007;232:176–183
- Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer. 2003;47:40–47
- Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev. 2002;11:1689–1696
- . Calcium, vitamin D and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005;14:525–528
- . Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16:159–178
- . Tumor inflammatory angiogenesis and chemoprevention. Cancer Res. 2005;65:10637–10641
- . Antioangiogenic activity of chemopreventive drugs. Int J Biol Markers. 2003;18:70–74
- Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp. 1998;63:295–313
- . Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth and angiogenesis. Exp Biol Med. 2006;31:20–27
- . Antiangiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev. 2008;27:229–238
- . Regulation of matrix metallopreoteinase expression in tumor invasion. FASEB J. 1999;13:781–792
- . Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents. Curr Cancer Drug Targets. 2007;7:475–483
- . Tumor angiogenesis—a potential target in cancer chemoprevention. Food Chem Toxicol. 2008;46:1334–1345
- . Nutraceuticals as anti-angiogenic agents: hopes and reality. J Physiol Pharmacol. 2005;56:51–69
- . Inflammation and cancer: how hot is the link?. Biochem Pharmacol. 2006;72:1605–1621
- . Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci. 2008;99:836–842
- . The STATs of cancer: new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105
- Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res. 2007;13:3024–3032
- . Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter. 2007;12:510–517
- Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109:2293–2302
- . Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15:425–430
- Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491–4499
- . Cell cycle-dependent effects of 3,3′-diindolylmethane on proliferation and apoptosis of prostate cancer cells. J Cell Physiol. 2009;219:94–99
- . Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cells. Mol Carcinog. 2009;48:260–270
- A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res. 2008;68:8564–8572
- Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prev Res. 2009;2:60–69
- . Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 2009;11:241–249
- . Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis. 2007;28:1188–1196
- . Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res. 2007;13:1061–1067
- . Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis. 2006;27:2301–2307
- Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer. 2006;54:58–68
- Anti-angiogenic property of edible berries. Free Radic Res. 2002;36:1023–1031
- Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res. 2004;64:644–651
- Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res. 2008;68:227–235
- Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene. 2007;26:1067–1077
- 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis. 2005;26:771–778
- . Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885–897
- Green tea polyphenol (–)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Invest. 2006;36:113–122
- . Trans-3,4,5′-trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res. 2004;10:5253–5263
- . Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther. 2005;4:1465–1474
- . Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther. 2006;5:1227–1238
- Energy intake and prostate tumor growth, angiogeneis, and vascular endothelial growth factor expression. J Natl Cancer Inst. 1999;91:512–523
- . Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002;86:1615–1621
- . Interrelationships between dietary restriction, the IGF-1 axis, and the expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. Mol Carcinog. 2008;47:458–465
- . Nutrigenetics: links between genetic background and response to Mediterranean-type diets. Public Health Nutr. 2009;12:1601–1606
- . Interactions between reactive oxygen species and cancer: the roles of natural dietary antioxidants and their molecular mechanisms of action. Asian Pac J Cancer Prev. 2009;10:535–544
- . A review of the interactions among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 2007;18:567–579
PII: S0093-7754(10)00066-7
doi: 10.1053/j.seminoncol.2010.05.001
« Previous
Next »
Seminars in Oncology
Volume 37, Issue 3
, Pages 243-257
, June 2010
